Chiromics is prospecting new molecular space
through creation of Accessible Complexity: unique and diverse drug-like small molecule collections that are stereochemically complex generated by Chiromics proprietary technology.

Chiromics' cutting-edge technology enables the creation of "Accessible Complexity": defined as new stereochemically complex molecular space made accessible by organocascade catalysis.

Creation of Accessible Complexity allows the assembly of the most powerful collection of molecular structures that will have a dynamic impact on the initiation and acceleration of drug discovery programs. The Chiromics molecular pipeline is continually evolving at a fast pace with the advancement in the field of Organocatalysis.

Through our industrial collaborators and our in house drug discovery paradigm, Chiromics has explored targets in the therapeutic areas of immunology, cardiovascular, oncology, virology and neuroscience.

>> Read more

Website by Princeton Internet Group, Inc. (PING)